The SPAC wave of 2020 is the most notable development of the year in the equity capital markets. SPACs have incredibly flexible structure that can meet a wide number of needs says Jocelyn Arel, a partner at Goodwin who heads the firm’s SPAC practice and advised Cerevel Therapeutics Inc. earlier this year on its agreement to merge with Arya Sciences Acquisition Corp. II (ARYB). Read the article in The Deal here.
October 29, 2020